Home
Mapp Biopharmaceutical, Inc.

Mapp Biopharmaceutical, ... Market Share Analysis for May 2026

Mapp Biopharmaceutical develops novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on global health and biodefense.

Industry: N/A

Domainmappbio.com

Year Founded2003

Employees51 - 200

Annual Revenue$10M - $15M

Mapp Biopharmaceutical, Inc.

Mapp Biopharmaceutical, Inc. (including company regionals)

mappbio.com

See more website traffic and engagement information

Mapp Biopharmaceutical, Inc. Revenue up to May 2026 is 10M - 15M

revenue generated by Mapp Biopharmaceutical, Inc. top domains

Mapp Biopharmaceutical, Inc. top domains revenue over 3 years

Revenue for Mapp Biopharmaceutical, Inc. top domains

mappbio.com10M - 15M

See more with Sales Intelligence

Total visits to Mapp Biopharmaceutical, Inc.'s top domains

Understand Mapp Biopharmaceutical, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mappbio.com2.5K

See more with Sales Intelligence

Avg. visit duration in Mapp Biopharmaceutical, Inc.'s top domains

Analyze Mapp Biopharmaceutical, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mappbio.com--

See more with Sales Intelligence

Avg. pageviews on Mapp Biopharmaceutical, Inc.'s top domains

See how Mapp Biopharmaceutical, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mappbio.com1.09

See more with Sales Intelligence

Mapp Biopharmaceutical, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

fortebio.comCompany NameForteBioEmployees51 - 200HQUnited States, California, FremontAnnual revenue$25M - $50MTotal visits--Science and Education > Biology

Top technologies used by Mapp Biopharmaceutical, Inc.

These are the website technologies, by industry, used by Mapp Biopharmaceutical, Inc. top domains

Widget (4)

Twemoji

Conversion & Analytics (3)

Google Analytics

Advertising (2)

Google Adsense

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Mapp Biopharmaceutical, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMappbio partnered with Medical Countermeasures on May 11th '26.Mapp, which developed the antibody treatment ZMAPP during the 2014-2016 Ebola outbreak in West Africa, is working with the Biomedical Advanced Research and Development Authority, or BARDA, to supply the treatment for potential use in high-risk individuals, a U.S. official said on Wednesday.

NewsMappbio is developing pan-ebolavirus antibody drug.Privately held Mapp Biopharmaceutical is developing a pan-ebolavirus antibody drug involving a combination of two human monoclonal antibodies, MBP134.

NewsMappbio recognized as leading therapeutic candidates..The WHO named Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab, and Gilead Sciences' antiviral remdesivir as the leading therapeutic candidates.[1] The agency, working alongside outside experts, has been engaged in a broader effort to identify viable candidates for both treatment and prevention, a pressing task given that there are currently no approved vaccines or therapies specifically targeting Bundibugyo virus disease.[1]